2 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| PsychonautWiki | Pharmacology | ||
|---|---|---|---|
| Classification | |||
| Class / category | — | ||
| Also known as | N-Acetylcysteine | — | |
| Safety | |||
| Dose · Oral | |||
| Threshold | 100 mg | — | |
| Light | 400–600 mg | — | |
| Common | 600–1000 mg | — | |
| Strong | 1000–1500 mg | — | |
| Heavy | 1500 mg+ | — | |
| Duration | |||
| Onset | 20–60 minutes | — | |
| Total | 3–6 hours | — | |
| Pharmacology | |||
| Receptor activity | — | Solute carrier family 22 member 6 | |
| Half-life | — | The mean terminal half life of acetylcysteine in adults is 5.6 hours and in pre-term neonates is 11 hours. Following IV administration of acetylcysteine, mean elimination half lives of 5.6 and 11 hours have been reported in adults and in neonates, respectively. The mean elimination half life was increased by 80% in patients with severe liver damage (i.e., alcoholic cirrhosis (Child-Pugh score of 7-13) or primary and/or secondary biliary cirrhosis (Child-Pugh score of 5-11)). | |
| Protein binding | — | Acetylcysteine is 66-97% protein bound in serum, usually to albumin. | |
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.